External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)

European Urology Open Science - Tập 33 - Trang 89-93 - 2021
Zine-Eddine Khene1, Alessandro Larcher2, Jean-Christophe Bernhard3, Nicolas Doumerc4, Idir Ouzaid5, Umberto Capitanio2, François-Xavier Nouhaud6, Romain Boissier7, Nathalie Rioux-Leclercq8, Alexandre De La Taille9, Philippe Barthelemy10, Francesco Montorsi2, Morgan Rouprêt11, Pierre Bigot12, Karim Bensalah1
1Department of Urology, University of Rennes, Rennes, France
2Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
3Department of Urology, University of Bordeaux, Bordeaux, France
4Department of Urology, University of Toulouse, Toulouse, France
5Department of Urology, Bichat Claude Bernard Hospital, Paris, France
6Department of Urology, University Hospital of Rouen, Rouen, France
7Department of Urology, Aix-Marseille University, Marseille, France
8Department of Pathology, University of Rennes, Rennes, France
9Department of Urology, Mondor Hospital, Créteil, France
10Department of Oncology, University of Strasbourg, Strasbourg, France
11Department of Urology, La Pitie Salpétrière Hospital, Paris, France
12Department of Urology, University of Angers, Angers, France

Tài liệu tham khảo

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Dabestani, 2016, Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study, World J Urol, 34, 1081, 10.1007/s00345-016-1773-y Dabestani, 2018, Follow-up after curative treatment of localised renal cell carcinoma, World J Urol, 36, 1953, 10.1007/s00345-018-2338-z Graham, 2018, Prognostication in kidney cancer: recent advances and future directions, J Clin Oncol, 36, 3567, 10.1200/JCO.2018.79.0147 Correa, 2021, Predicting disease recurrence, early progression, and overall survival following surgical resection for high-risk localized and locally advanced renal cell carcinoma, Eur Urol, 80, 20, 10.1016/j.eururo.2021.02.025 Zisman, 2002, Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma, J Clin Oncol, 20, 4559, 10.1200/JCO.2002.05.111 Leibovich, 2018, Predicting oncologic outcomes in renal cell carcinoma after surgery, Eur Urol, 73, 772, 10.1016/j.eururo.2018.01.005 Maurice, 2016, Increased use of partial nephrectomy to treat high-risk disease, BJU Int, 117, E75, 10.1111/bju.13262 Mir, 2017, Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies, Eur Urol, 71, 606, 10.1016/j.eururo.2016.08.060 Williamson, 2018, Challenges in pathologic staging of renal cell carcinoma: a study of interobserver variability among urologic pathologists, Am J Surg Pathol, 42, 1253, 10.1097/PAS.0000000000001087 Royston, 2013, External validation of a Cox prognostic model: principles and methods, BMC Med Res Methodol, 13, 33, 10.1186/1471-2288-13-33 Pajouheshnia, 2019, When and how to use data from randomised trials to develop or validate prognostic models, BMJ, 365, l2154, 10.1136/bmj.l2154
Thông tin
Thông tin xuất bản

European Urology Open Science

Tập 33

89-93

Thông tin tác giả